|
|||||
AmphadaseActive Ingredient(s): HyaluronidaseFirst Approved by the FDA: October 26, 2004 Pharmaceutical Company: AMPHASTAR PHARM Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to AmphadaseInjection 1,500 units/vial, 150 units/ml, 150 units/vial, 150unit/ml, 150USPunits/ml, 200 units/vial, 200units/ml, 6,200 units/vial Powder for Reconstitution 6200IU/5ml Related Drug Page(s): Related Search Results for AmphadaseWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Amphadase Text Link HTML Code: Related: Amphadase doctor, Amphadase document care pharma types treatment, shape class lookup news material Amphadase, control overdosage natural Amphadase, almanac online discussions details Amphadase, Amphadase withdrawal, Amphadase value value about imprint trials, symptoms druggist Amphadase, Amphadase effect community, Amphadase value technical meds pills description. Hyaluronidase picture treat, identify meds rx medicine drugs Hyaluronidase, Hyaluronidase company treat control search, reactions digest Hyaluronidase, Hyaluronidase rx discuss, rx imprint efficacy policy Hyaluronidase. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Amphadase.asp Last Updated June 26 2005 |
|||||